Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.28-0.44 (-0.75%)
At close: 04:00PM EDT
56.53 -1.75 (-3.00%)
After hours: 06:07PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/19/2022
Current
3/31/202212/31/20219/30/20216/30/20213/31/2021
Market Cap (intraday)
5.52B5.75B4.29B3.03B3.32B2.75B
Enterprise Value
4.77B5.37B3.84B2.51B2.74B2.12B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
48.8160.8561.7953.5181.50105.97
Price/Book (mrq)
6.9613.778.815.485.424.19
Enterprise Value/Revenue
47.29154.40150.30116.00143.92136.37
Enterprise Value/EBITDA
-15.66-74.03-44.67-32.47-39.63-40.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 349.86%
S&P500 52-Week Change 3-1.04%
52 Week High 366.00
52 Week Low 328.40
50-Day Moving Average 357.76
200-Day Moving Average 346.65

Share Statistics

Avg Vol (3 month) 3928.47k
Avg Vol (10 day) 3792.24k
Shares Outstanding 594.32M
Implied Shares Outstanding 6N/A
Float 887.29M
% Held by Insiders 12.43%
% Held by Institutions 192.26%
Shares Short (May 12, 2022) 43.84M
Short Ratio (May 12, 2022) 43.83
Short % of Float (May 12, 2022) 44.69%
Short % of Shares Outstanding (May 12, 2022) 44.07%
Shares Short (prior month Apr 13, 2022) 43.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -294.89%
Operating Margin (ttm)-296.47%

Management Effectiveness

Return on Assets (ttm)-24.72%
Return on Equity (ttm)-43.21%

Income Statement

Revenue (ttm)102.92M
Revenue Per Share (ttm)1.22
Quarterly Revenue Growth (yoy)120.40%
Gross Profit (ttm)-13.08M
EBITDA -304.55M
Net Income Avi to Common (ttm)-303.5M
Diluted EPS (ttm)-3.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)771.85M
Total Cash Per Share (mrq)8.18
Total Debt (mrq)24.39M
Total Debt/Equity (mrq)3.08
Current Ratio (mrq)14.36
Book Value Per Share (mrq)8.43

Cash Flow Statement

Operating Cash Flow (ttm)-294.63M
Levered Free Cash Flow (ttm)-177.29M
Advertisement
Advertisement